Some of biopharma’s biggest assets face a solo existence

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 19, 2020 at 8:42 PM.

  1. #1 cafead, Nov 19, 2020 at 8:42 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,932
    Likes Received:
    3
    via A clinical trial using a statistical method that had prompted some criticism has catapulted Allakos and its lead asset, lirentelimab, to the top of a ranking of biotech assets that have yet to attract a significant partner, EvaluatePharma data show.

    article source
     
    Quote

Reply to Thread